| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
Revenue  | 15 | 17 | 17 | 8 | 6 | 7 | 6 | 1 | 1 | 0 | 0 |
| Expenses | 14 | 17 | 16 | 7 | 5 | 10 | 7 | 1 | 1 | 0 | 0 |
| EBITDA | 1 | 1 | 1 | 1 | 1 | -3 | -0 | -0 | 0 | -0 | -0 |
| Operating Profit % | 6 % | 3 % | 7 % | 11 % | 11 % | -51 % | -4 % | -40 % | 0 % | 0 % | 0 % |
| Depreciation | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | -4 | -1 | 1 | -4 | -0 | -0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | -4 | -1 | 1 | -4 | -0 | -0 |
| EPS in ₹ | 0.04 | 0.02 | 0.01 | 0.00 | 0.05 | -6.45 | -2.19 | 1.23 | -7.24 | -0.25 | 0.00 |
Adline Chem Lab
13.95
0.00
(0.00%)
Market Cap
8.20 Cr
EPS
-0.25
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
27.27
52 Week low
11.92
PB Ratio
-5.16
Debt to Equity
0.00
Sector
Pharmaceuticals
Live Chart 
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
| 1,683.45 | 4,03,916.05 | 34.10 | 49,887.20 | 12.06 | 9,648 | 13.77 | 52.67 | |
| 5,620.45 | 1,49,205.29 | 72.77 | 8,184.00 | 0.89 | 1,600 | 64.53 | 45.57 | |
| 1,461.90 | 1,18,065.10 | 23.53 | 26,520.70 | 14.17 | 4,155 | 47.38 | 52.92 | |
| 3,056.05 | 1,03,430.62 | 56.27 | 10,785.70 | 11.59 | 1,656 | 13.54 | 47.23 | |
| 1,107.95 | 92,448.55 | 17.17 | 28,905.40 | 12.36 | 5,578 | 1.69 | 30.37 | |
| 2,201.15 | 90,812.16 | 43.84 | 10,615.60 | 19.57 | 1,942 | -16.38 | 35.15 | |
| 1,968.45 | 89,800.21 | 31.28 | 20,141.50 | 19.94 | 1,936 | 38.82 | 43.62 | |
| 883.10 | 88,860.52 | 19.73 | 19,831.50 | 13.82 | 3,831 | 29.92 | 40.81 | |
| 1,094.75 | 63,583.26 | 18.24 | 29,559.20 | 17.55 | 3,169 | -10.04 | 43.94 | |
| 29,597.00 | 62,891.56 | 47.49 | 6,097.20 | 10.80 | 1,201 | 16.01 | 49.75 |
Growth Rate
Revenue Growth
-100.00 %
Net Income Growth
-97.62 %
Cash Flow Change
-300.00 %
ROE
-96.83 %
ROCE
-96.98 %
EBITDA Margin (Avg.)
-2,437.79 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 19 | 18 | 21 | 23 | 22 | 8 | 6 | 5 | 0 | 0 |
| Fixed Assets | 10 | 10 | 13 | 13 | 12 | 5 | 4 | 4 | 0 | 0 |
| Current Assets | 7 | 7 | 8 | 11 | 10 | 3 | 2 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 8 | 8 | 8 | 11 | 10 | 3 | 2 | 0 | 0 | 0 |
| Total Liabilities | 19 | 18 | 21 | 23 | 22 | 8 | 6 | 5 | 0 | 0 |
| Current Liabilities | 6 | 7 | 10 | 12 | 15 | 4 | 3 | 2 | 1 | 2 |
| Non Current Liabilities | 6 | 5 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 7 | 7 | 7 | 7 | 7 | 3 | 2 | 3 | -2 | -2 |
| Reserve & Surplus | 1 | 1 | 1 | 1 | 1 | -3 | -4 | -3 | -7 | -8 |
| Share Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 0 | -0 | -0 | 2 | -2 | -0 | -0 | 0 | 0 | 0 |
| Investing Activities | -2 | -0 | -3 | -0 | -0 | 11 | 0 | 0 | 0 | 0 |
| Operating Activities | 0 | 1 | 3 | 1 | -1 | -11 | -0 | 0 | 0 | 0 |
| Financing Activities | 2 | -1 | 1 | 1 | -0 | 0 | 0 | 0 | 0 | 0 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
| Promoter | 31.46 % | 31.46 % | 30.45 % | 30.17 % | 30.17 % | 30.17 % | 28.24 % | 28.24 % | 28.24 % | 28.24 % | 28.24 % | 28.24 % | 29.61 % | 29.61 % | 29.61 % | 29.61 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 58.27 % | 58.27 % | 59.27 % | 59.28 % | 59.29 % | 59.29 % | 61.25 % | 61.51 % | 61.51 % | 61.52 % | 61.53 % | 61.63 % | 60.29 % | 60.30 % | 60.32 % | 60.15 % |
| Others | 10.28 % | 10.28 % | 10.28 % | 10.55 % | 10.54 % | 10.54 % | 10.52 % | 10.25 % | 10.25 % | 10.24 % | 10.23 % | 10.14 % | 10.10 % | 10.09 % | 10.07 % | 10.24 % |
| No of Share Holders | 18,705 | 18,704 | 18,704 | 18,700 | 18,695 | 18,689 | 18,686 | 18,678 | 18,670 | 18,661 | 18,638 | 18,628 | 18,595 | 18,583 | 18,536 | 18,509 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
No dividends have been distributed by the company in the past 10 years
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Integrated Filing (Financial)
Disclosure Regarding Submission Of Application Under Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Re-Classification Of Promoters
Announcement under Regulation 30 (LODR)-Newspaper Publication
Results For Quarter And Nine Months Ended On 31St December 2024.
Board Meeting Outcome for Outcome Of Board Of Directors Meeting Of Adline Chem Lab Limited Held On 4Th February 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Shareholder Meeting / Postal Ballot-Outcome of EGM
NON-APPLICABILITY OF STATEMENT OF DEVIATION & VARIATION UNDER REGULATION 32 OF SEBI (LODR) REGULATIONS 2015
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Intimation For Change Of Name Of Registrar & Share Transfer Agent Of The Company
Closure of Trading Window
Extract Of Board Meeting Held On Wednesday, 11Th December, 2024
Announcement under Regulation 30 (LODR)-Change in Directorate
Board Meeting Outcome for Outcome Of Board Meeting To Be Held 11Th December, 2024
Board Meeting Intimation for Intimation Of Board Meeting To Be Held 11Th December, 2024
Announcement under Regulation 30 (LODR)-Change in Directorate
Announcement under Regulation 30 (LODR)-Resignation of Director
Announcement under Regulation 30 (LODR)-Newspaper Publication
Intimation Pertaining To Requests Received For Reclassification Of Shareholding From 'Promoter And Promoter Group' Category To 'Public' Category As Per Regulation 31A Of SEBI (LODR) Regulations, 2015
Results For Financial Results For Quarter And Half Year Ended 30Th September, 2024.
Non Applicability Of Disclosure Under Regulation 23(9) Of SEBI (LODR) Regulations, 2015 For The Quarter And Half Year Ended On 30Th September, 2024
Board Meeting Outcome for Outcome Of Board Of Directors Meeting Of Adline Chem Lab Limited
Board Meeting Intimation for Intimation Regarding Postponement Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Shareholder Meeting / Postal Ballot-Outcome of AGM
Closure of Trading Window
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Announcement under Regulation 30 (LODR)-Newspaper Publication
Reg. 34 (1) Annual Report.
Outcome Of The Board Meeting For AGM Related Agendas
Board Meeting Outcome for Outcome And Disclosure Under Regulation 30 Of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Announcement under Regulation 30 (LODR)-Resignation of Director
Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
Announcement under Regulation 30 (LODR)-Newspaper Publication
Board Meeting Outcome for Outcome Of The Board Meeting Held On 15.07.2024 For Unaudited Financial Results For The Quarter Ended 30Th June, 2024
Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Closure of Trading Window
Technical Indicators
RSI(14)
Neutral 23.74
ATR(14)
Less Volatile 0.89
STOCH(9,6)
Oversold 2.39
STOCH RSI(14)
Oversold 0.00
MACD(12,26)
Bearish -0.75
ADX(14)
Strong Trend 34.42
UO(9)
Bullish 22.52
ROC(12)
Downtrend And Accelerating -34.20
WillR(14)
Oversold -100.00
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
